Market Overview

Top 4 NYSE Stocks In The Drug Delivery Industry With The Highest Revenue

Share:
Related HSP
UPDATE: Hospira Q4 Earnings Top Estimates
Earnings Scheduled For February 12, 2015
Seeking Alpha's Biotech Weekly: Achillion Overdone, Sanofi's Toujeo A Go, And More (Seeking Alpha)
Related VRX
Morgan Stanley Reiterates Overweight, Raises Price Target On Valeant Pharmaceuticals On New Proforma Model For SLXP
Here's Why CRT Capital Boosted Valeant Pharmaceuticals' Price Target
Meet IBD's 4 A Stocks With Rising Earnings Estimates (Investor's Business Daily)

Below are the top drug delivery stocks on the NYSE in terms of revenue.

The trailing-twelve-month revenue at Hospira (NYSE: HSP) is $4.02 billion. Hospira had $655.90 million in total cash for the latest quarter.

The trailing-twelve-month revenue at Valeant Pharmaceuticals International (NYSE: VRX) is $2.75 billion. Valeant Pharmaceuticals' operating margin for the same period is 23.99%.

The trailing-twelve-month revenue at Elan Corporation plc (NYSE: ELN) is $1.29 billion. Elan's ROE for the same period is 102.84%.

The trailing-twelve-month revenue at K-V Pharmaceutical Company (NYSE: KV-A) is $23.20 million. K-V Pharmaceutical had $50.70 million in total cash for the latest quarter.

Posted-In: Drug Delivery Industry Highest Revenue NYSETrading Ideas

 

Related Articles (ELN + HSP)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Benzinga PRO content